Switch to
More onapp

How to use scorecard? Learn more

Ajanta Pharma Ltd

AJANTPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹14,867 cr, stock is ranked 261
Low RiskStock is 1.69x as volatile as Nifty
1,209.000.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹14,867 cr, stock is ranked 261
Low RiskStock is 1.69x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
24.10
PB RatioPB Ratio
4.55
Dividend YieldDiv. Yield
0.55%
Sector PESector PE
32.89
Sector PBSector PB
4.06
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

82%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.

Financial TrendFinancial statements 

20192020202120222.082.682.923.460.390.470.650.71
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 4.37%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 2.43%

See detailed holdings

Recent EventsAll events 

Buyback 
Announced OnMar 28, 2023

Ajanta Pharma Limited has informed the Exchange about submission of Letter of Offer | Download

Ajanta Pharma Limited has informed the Exchange about submission of Letter of Offer | Download

Buyback 
Announced OnMar 28, 2023

Ajanta Pharma Limited has informed the Exchange about submission of Letter of Offer | Download

Ajanta Pharma Limited has informed the Exchange about submission of Letter of Offer | Download

Cash Dividend 
Ex. DateNov 11, 2022

Interim • Div/Share: ₹ 7

See all events